Javascript Menu by Deluxe-Menu.com

Advanced Search
  Home Breaking News Newsletters Books & Reports Events Jobs Advisory Board Interviews e-Alert Contact Us
     
 
G2 Reports Advisory Board




Joseph W. Plandowski

Joseph W. Plandowski has broad experience in operations, sales/marketing, and acquisitions in the healthcare field. He has managed small and large laboratories, commercial and hospital-owned, and is particularly adept at turning around operations, managing the integration of mergers and acquisitions, increasing the profitability of medical practices, and negotiating the sale or acquisition of laboratories and pathology practices.

It was with biological and medical products of Union Carbide that Plandowski began his career, initially in technical design, then in sales and sales management. He progressed through product management to director of sales/marketing, overseeing product sales, field engineering, technical services, and reagents.

From Union Carbide, Plandowski joined SmithKline Clinical Laboratories as general manager in Tampa responsible for growing its Florida operations. Subsequently, he was given responsibility as vice president, based in St. Louis, to grow the company's central and western United States and Canadian operations. He started SmithKline’s Houston and San Francisco laboratories and acquired laboratories in Cleveland, Minneapolis, and Seattle. Upon successfully integrating BioScience Laboratories into SmithKline's Los Angeles laboratory, he was made head of operations of all SmithKline’s clinical laboratories in the United States and Canada.

Prior to becoming president/CEO and a member of the board of directors of Genetrix, Plandowski was executive vice president of sales and marketing at Allscrips Pharmaceuticals. Allscrips provided prepackaged pharmaceuticals to physicians for dispensing directly to their patients. Genetrix specialized in performing cytogenetic testing for prenatal and oncology clinicians at its laboratories across the country.

When National Health Laboratories decided to pursue an aggressive acquisitions program, Plandowski joined as vice president of acquisitions. More than 50 laboratory acquisitions were closed in a two-year period. With the merger of National Health Laboratories and Roche BioMedical Laboratories to create Laboratory Corporation of America, he formed Lakewood Consulting Group, an anatomic and clinical laboratory and pathology practice management and consulting firm.

Plandowski holds a bachelor’s degree in mechanical engineering and a master’s in business administration from the State University of New York at Buffalo. He is a member of the Clinical Laboratory Management Association, the Association for Pathology Informatics, the National Society of Histotechnology, the American Society for Cytotechnology, the American Pathology Foundation, and the American Society of Cytopathology. He is a speaker at national meetings and is frequently quoted in publications serving both the laboratory industry and pathology.

Latest Articles:

04/22/08 - Global CPT 88305 on Sale for $30?
01/15/08 - Pathologists and Pod Labs
11/15/07 - How Much More of a Financial Beating Can Pathologists Withstand?
10/09/07 - Insourcing AP Services by Physician Specialty Groups: Practice and Business Implications for Pathologists
10/09/07 - Competitive Bidding by CMS for Clinical Laboratory Testing
About G2 Awards & Scholarships Blogs & Online Resources Advertising List Rentals Renewels Privacy
Copyright © 1999-2008 Washington G-2 Reports.
No portion of the material presented on this site may be used without express written permission from authorized personnel at Washington G-2 Reports.
Washington G-2 Reports is an operating unit of IOMA, the Institute of Management & Administration, Inc.